• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » In Brief

In Brief

May 7, 2020
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Psychiatric Effects of the Chloroquines: During the coronavirus outbreak, prescriptions for chloroquine and hydroxychloroquine have climbed 5-fold to 10-fold as as people turn to these experimental therapies for COVID-19. Their psychiatric properties are worth knowing. The chloroquines readily cross the blood-brain barrier, where they create a number of undesirable effects, increasing serotonin, acetylcholine, and glutamatergic transmission and causing toxic metabolites to accumulate. The drugs have known associations with suicide, psychosis, mania, and depression (Mascolo A et al, Inflammopharmacology 2018;26(5):1141–1149).


Drug interactions are another problem. As moderate CYP2D6 inhibitors, the chloroquines can raise levels of many psychiatric medications. They also prolong QTc and increase the risk of neutropenia on clozapine. These effects can linger, as the chloroquines have unusually long half-lives of 20–40 days.


Lithium and the Coronavirus: Lithium has also been proposed as a potential therapy for COVID-19. Lithium improves immune function, increasing neutrophils, lymphocytes, leukocytes, and natural killer cells. It also has direct antiviral activity. It has been used to treat herpes and impedes the replication of over a dozen viruses, including four coronavirus strands. Lithium has never been tested against the current novel coronavirus (Nowalk JK and Walkowiak J, F1000Research 2020;9(93)).


While lithium’s properties may be welcome news for patients who are taking it, they should be warned that viral illnesses raise the risk of lithium toxicity, mainly through dehydration, diarrhea, and the use of nonsteroidal anti-inflammatories (NSAIDs), which raise lithium levels by unpredictable degrees.


General Psychiatry
www.thecarlatreport.com
Issue Date: May 7, 2020
SUBSCRIBE NOW
Table Of Contents
CME Post-Test - Telepsychiatry, TCPR, May 2020
In Brief
Trazodone: The Forgotten Antidepressant
Telepsychiatry: From Crisis to Opportunity
A Potentially Lethal Side Effect You Probably Never Heard Of
Study Ignites Controversy Over Trazodone and Suicide
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.